Indication

Patent ductus arteriosus

Patent ductus arteriosus is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus—a fetal vascular shunt connecting the proximal descending aorta to the pulmonary artery—to close spontaneously after birth. Read more about Patent ductus arteriosus

12 drugs 10 manufacturers

Advertisement

Drugs that treat it

Common Patent ductus arteriosus therapies.

Showing 10–12 of 12 drugs

Filter & compare in the drug finder →Opens the drug finder with Patent ductus arteriosus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Patent ductus arteriosus.

Patent ductus arteriosus is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus—a fetal vascular shunt connecting the proximal descending aorta to the pulmonary artery—to close spontaneously after birth.

Primarily affecting neonates, with an incidence inversely proportional to gestational age and birth weight, it is particularly prevalent in premature infants.

Persistence of this duct leads to pathological left-to-right shunting of oxygenated blood from the high-pressure systemic circulation into the low-pressure pulmonary circulation.

This hemodynamic alteration produces pulmonary overcirculation, systemic hypoperfusion, and volume overload, clinically manifesting with findings such as a continuous murmur, bounding peripheral pulses, tachypnea, and an increased risk of congestive heart failure.

Personalize your experience

Follow Patent ductus arteriosus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it